Treatment of Vulvar Intraepithelial Neoplasia With CO2 Laser Vaporization and Excision Surgery
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 17 (4) , 446-451
Abstract
Objective To evaluate the recurrence rate after a single treatment of vulvar intraepithelial neoplasia (VIN) with CO2 laser vaporization. Materials and Methods Fifty women with usual-type or differentiated VIN (grades 2 and 3) treated with CO2 laser vaporization or surgery excision (cold knife or CO2 laser) were retrospectively evaluated. Results Of the 50 patients, 41 (82.0%) had usual-type VIN and 9 (18.0%) had differentiated VIN. Moreover, 24 (48.0%) were treated with surgery excision and 26 (52.0%) underwent CO2 laser vaporization. Laser-treated patients were significantly younger (p < .01) with more multifocal (p < .05) and multicentric lesions (p < .01) than in the surgery group. Recurrence-free survival (RFS) rates at 1 year were 91.0% for the surgery and 65.2% for the laser vaporization groups (p < .01). At 5 years, RFS rates were unchanged for the surgery group and dropped to 51.3% (p < .01) for the laser group. On the univariate analysis, current smoker (p = .03), multicentric VIN (p = .02), and laser vaporization treatment (p < .01) had a statistically significant impact on RFS. One patient progressed to invasive cancer (2%). Conclusions The recurrence rate after CO2 laser vaporization requires regular, close, and extended monitoring.Keywords
This publication has 20 references indexed in Scilit:
- Proceedings of the 2012 ASCCP Biennial Scientific Meeting Oral and Poster Abstract PresentationsJournal of Lower Genital Tract Disease, 2012
- Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasiaInternational Journal of Gynecology & Obstetrics, 2008
- Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomised, double-blinded studyGynecologic Oncology, 2007
- HPV‐related vulvar intraepithelial neoplasia: Outcome of different management modalitiesInternational Journal of Gynecology & Obstetrics, 2007
- Risikofaktoren der Rezidivhäufigkeit von vulvären intraepithelialen Neoplasien Grad III (VIN III)Zentralblatt Fur Gynakologie, 2006
- Trends in the Incidence of Invasive and In Situ Vulvar CarcinomaObstetrics & Gynecology, 2006
- Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomyGynecologic Oncology, 2006
- Preliminary results of 5% immiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3American Journal of Obstetrics and Gynecology, 2006
- Vulvar Intraepithelial NeoplasiaObstetrics & Gynecology, 2005
- Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patientsGynecologic Oncology, 2005